6th year Flashcards
HPV vaccines
- Cervarix: 16, 18
- Gardasil: 6, 11, 16, 18
- Gardasil 9: 6, 11, 16, 18, 31, 33, 45, 52, 58
Bethesda system
Squamous cell cc
- ASC-US
- (ASC-H)
- LSIL
- HSIL
- Invasive carcinoma
Adenocc
- ACG
- AIS
- Adenocc
Richard system
- Condyloma
- CIN 1
- CIN 2
- CIN 3
- Invasive carcinoma
Papanicolou system
- P1: negative
- P2: some benign aberration
- P3: pathological cells (inflame vs dysplasia??)
- P4: suspect malignancy
- P5: true malignancy
Reagan system (WHO)
- Normal
- Atypia
- Mild dysplasia
- Moderate dysplasia
- Severe dysplasia
- Carcinoma in situ
- Invasive carcinoma
RMI score
Risk of malignancy index for ovarian masses
- Menopausal status (pre=1p, post=3p)
- US morphology (multiloculated, solid areas, bilateral, ascites, intraabd metastases. Score 0-1 => U=1p, Score 2-5 => U=3p)
- CA-125 absolute value
MxUxCA125 = ? (over 200 is suspicious)
ROMA score ovarian masses
- HE4
- CA-125
- Menopausal status
Treatment ovarian cc
Requires surgical exploration and intraop. frozen section
Stage
- IA: TAH-BSO (pregnancy-wish: USO=>fast pregnancy=>TAH-BSO)
- IB: TAH-BSO
- IC: TAH-BSO + peritoneal radioactive phosphorous
- II-IV: TAH-BSO + omentectomy + debulking (cytoreductive surgery) + chemo (paclitaxel+carboplatin)
*Bevacizumab (anti-VEGF) might be added adjuvantly
Germ-cell tumors and Sex-cord stromal tumors: TAH-BSO + staging +/- adjuvant BEP (bleomycin, etopocide, cisplatin)
Treatment uterine cc
Stage I-II: TAH-BSO (fertility-sparing: medroxyprogesterone acetate)
Stage III-IV: TAH-BSO + radiation + platinums
Treatment cervical cc
Stage Ia1: TAH (fertility-sparing: conization)
Stage IIa: TARH + PLND (fertility-sparing: up to Ib1: radical trachelectomy + PLND)
Stage IIb-IIIb: Radiation + chemo (cisplatin, bleomycin, mitomycin C, methotrexate, cyclophosphamide)
Stage IV: Palliative chemo/radiation/surgery
Types of vaginal prolapse
- Cystocele: weak pubocervical fascia
- Rectocele: weak rectovaginal fascia
- Enterocele:
(4: Urethrocele/urethrocystocele?)
Uterine prolapse defects
- Cardinal ligaments
- Uterosacral ligaments
Treatment vaginal prolapse
- Pelvic floor exercises
- Pessaries - support in vagina
- Colporrhaphy (ant/post)
Treatment uterine prolapse
- Pelvis floor exercises
- Pessaries - support in vagina
- Hysterectomy with repair of pelvic support structures (colporrhaphy) and suspension of top of vagina
Treatment UTIs
Uncomplicated cystitis:
- Nitrofurantoin for 5 days -or- Trimethoprim/Sulfamethoxazole for 3 days
Acute pyelonephritis:
- 1st line: Ciprofloxacin 7 days & Levofloxacin 5 days
- 2nd line: TMP/SMX for 14 days
- Other options if hospitalization: ampi-genta or piperacillin/tazobactam
Treatment PID inpatient
- Lecture: Cefoxitin or Cefotetan + Doxycyclin
Norge: Cefotaxime + doxycyclin +/- metronidazole - Alt: Clindamycin + gentamycin
Treatment PID outpatient
- Lecture: Ceftriaxone + doxycyclin +/-metronidazole
Alkylating agents
Cyclophosphamide
- Ovarian carcinoma
- Germ cell tumors + (Gestational tumor - choriocc)
- Scc
- Breast cc
- Cervix cc
Antimetabolites
- Methotrexate: hydatidiform mole (with D&C), choriocarcinoma, breast, ectopic pregnancy, abortion (with misoprostol)
- 5-FU:
Antibiotics
- Actinomycin D: choriocarcinoma
- Doxorubicin: breast
- Bleomycin: cervix cc
Plant alkaloids
Paclitaxel: breast, ovarian, vaginal/vulvar cc
Platinum chemo
- Cisplatin: cervix cc, vaginal/vulvar cc
- Carboplatin: ovarian cc, uterine cc
Cell-cycle specific chemo
- G1: Actinomycin D
- S: Antimetabolites (mtx, 5-fu), doxorubicin
- G2: Bleomycin, etoposide
- M: taxanes, vinca alkaloids
Normal sperm and semen
- 2-5 ml semen
- > 20 million sperm/microliter
- > 30 % normal morphology
- > 50 % motile
Prenatal visits (GP)
- From gw 4 - 28: once a month
- GW 28 - 35: once every 2 weeks
- From gw 35: every week
Naegles rule
First day of LMP + 7 days - 3 months (+ add a year)